These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
579 related items for PubMed ID: 2946780
1. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. Thiele DL, Charley MR, Calomeni JA, Lipsky PE. J Immunol; 1987 Jan 01; 138(1):51-7. PubMed ID: 2946780 [Abstract] [Full Text] [Related]
2. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells. Thiele DL, Bryde SE, Lipsky PE. J Immunol; 1988 Nov 15; 141(10):3377-82. PubMed ID: 3053897 [Abstract] [Full Text] [Related]
3. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens. Thiele DL, Calomeni JA, Lipsky PE. J Immunol; 1987 Oct 01; 139(7):2137-42. PubMed ID: 3309052 [Abstract] [Full Text] [Related]
4. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes. Thiele DL, Eigenbrodt ML, Bryde SE, Eigenbrodt EH, Lipsky PE. J Clin Invest; 1989 Dec 01; 84(6):1947-56. PubMed ID: 2531761 [Abstract] [Full Text] [Related]
5. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS, Sharrow SO, Shearer GM. J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440 [Abstract] [Full Text] [Related]
6. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. Thiele DL, Lipsky PE. J Immunol; 1986 Feb 01; 136(3):1038-48. PubMed ID: 2934477 [Abstract] [Full Text] [Related]
7. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. Parkman R. J Immunol; 1986 May 15; 136(10):3543-8. PubMed ID: 2871104 [Abstract] [Full Text] [Related]
8. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets. Thiele DL, Lipsky PE. J Immunol; 1986 Aug 15; 137(4):1399-406. PubMed ID: 3488348 [Abstract] [Full Text] [Related]
9. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. Hamilton BL. J Immunol; 1987 Oct 15; 139(8):2511-5. PubMed ID: 3498761 [Abstract] [Full Text] [Related]
10. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes. Piguet PF, Janin-Mercier A, Vassalli P, Saurat JH. J Immunol; 1987 Jul 15; 139(2):406-10. PubMed ID: 2955041 [Abstract] [Full Text] [Related]
15. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Davenport C, George T, Devora GA, Morris MA, Gordon BE, Kumar V, Bennett M. Biol Blood Marrow Transplant; 1997 Dec 15; 3(6):294-303. PubMed ID: 9502296 [Abstract] [Full Text] [Related]
16. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD. Sprent J, Schaefer M, Korngold R. J Immunol; 1990 Apr 15; 144(8):2946-54. PubMed ID: 1969878 [Abstract] [Full Text] [Related]
17. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. Golding H, Mizuochi T, McCarthy SA, Cleveland CA, Singer A. J Immunol; 1987 Jan 01; 138(1):10-7. PubMed ID: 2946773 [Abstract] [Full Text] [Related]
18. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function. Moser M, Mizuochi T, Sharrow SO, Singer A, Shearer GM. J Immunol; 1987 Mar 01; 138(5):1355-62. PubMed ID: 2949013 [Abstract] [Full Text] [Related]
19. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Berger M, Wettstein PJ, Korngold R. Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395 [Abstract] [Full Text] [Related]